Keyphrases
Diabetic Retinopathy
100%
Carbon Dioxide
100%
Drug Substance
21%
Cmax
14%
CO Gas
14%
Carboxyhemoglobin (COHb)
14%
Administrative Approach
7%
Carbon Forms
7%
Clinical Trials
7%
Therapeutic Potential
7%
Hemoglobin
7%
Safety Data
7%
Neurovascular Complications
7%
Subarachnoid Hemorrhage
7%
Preclinical Data
7%
Carbon Monoxide Gas
7%
Carbon Monoxide Release
7%
Acute Respiratory Distress Syndrome
7%
Release Characteristics
7%
Further Development
7%
Chronic Use
7%
Diabetes Patients
7%
Healthy Adults
7%
Diabetes Mellitus Complications
7%
Tolerability
7%
Organic Molecules
7%
Phase II Clinical Trial
7%
Innovative Technologies
7%
Clinical Safety
7%
Carrier Molecules
7%
Phase 1 Clinical Trial
7%
Barriers to Growth
7%
Prodrug
7%
Working Adults
7%
Phase 1 Study
7%
Disease States
7%
Retinopathy
7%
Pharmacology, Toxicology and Pharmaceutical Science
Carbon Monoxide
50%
Diabetic Retinopathy
50%
Clinical Trial
6%
Preclinical Study
6%
Diseases
6%